NCT06885424Enrolling by invitation
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2Bio) Gene Therapy (GT) Products
Source: ClinicalTrials.gov · Last updated 20 May 2026
Brief summary (registry, in English)
This protocol is to ensure consistent long-term follow-up for delayed safety events in participants who received A2 Bio gene therapy (GT) products.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 12 Mar 2025
- Start date
- 31 Jul 2025
- Primary completion date
- 31 Mar 2030
- Lead sponsor
- A2 Biotherapeutics Inc.
- Diseases
- Triple-negative breast cancer, Head and neck cancer, Mesothelioma, Kidney cancer, Lung cancer, Pancreatic cancer, Colorectal cancer, Ovarian cancer
- NCT number
- NCT06885424
What you commit to
- Study type: Observational
- Planned participants: 400
- From 31 Jul 2025 to the primary completion date, 31 Mar 2030
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. There are no specific exclusion criteria for this study
Who the study is looking for
- Received any amount of A2 Bio GT product on a previous A2 Bio interventional study
- Able to provide written informed consent for this long-term follow-up study
- Able to comply with study requirements
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Banner Health Coordinator of this site? Confirm its status | Gilbert | United States | Unknown status |
| NYU Langone Medical Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.